期刊
EJSO
卷 43, 期 7, 页码 1282-1287出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ejso.2017.01.012
关键词
Breast cancer; Primary endocrine therapy; Surgery; Discrete choice experiment; Older
资金
- National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-1209-10071]
- National Institute for Health Research [RP-PG-1209-10071] Funding Source: researchfish
Introduction: Primary endocrine therapy (PET) is used variably in the UK as an alternative to surgery for older women with operable breast cancer. Guidelines state that only patients with significant comorbidity or reduced life expectancy should be treated this way and age should not be a factor. Methods: A Discrete Choice Experiment (DCE) was used to determine the impact of key variables (patient age, comorbidity, cognition, functional status, cancer stage, cancer biology) on healthcare professionals' (HCP) treatment preferences for operable breast cancer among older women. Multinomial logistic regression was used to identify associations. Results: 40% (258/641) of questionnaires were returned. Five variables (age, co-morbidity, cognition, functional status and cancer size) independently demonstrated a significant association with treatment preference (p < 0.05). Functional status was omitted from the multi variable model due to collinearity, with all other variables correlating with a preference for operative treatment over no preference (p < 0.05). Only co-morbidity, cognition and cancer size correlated with a preference for PET over no preference (p < 0.05). Conclusion: The majority of respondents selected treatment in accordance with current guidelines, however in some scenarios, opinion was divided, and age did appear to be an independent factor that HCPs considered when making a treatment decision in this population. (C) 2017 Elsevier Ltd, BASO - The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据